Thus, we believe that α-lactalbumin vaccination may be both safe and effective in preventing TNBC in women with BRCA1 mutations who often have >80% lifetime risk for developing breast cancer with TNBC being the most common variant of this disease occurring in this high risk population [9,10]. This evidence concerns the gene BRCA1 and breast carcinoma.